These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7553298)

  • 21. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of the significance of vascular invasion in bladder cancer].
    Honda N; Matsumoto K; Segawa A
    Nihon Hinyokika Gakkai Zasshi; 1983 Feb; 74(2):218-25. PubMed ID: 6865159
    [No Abstract]   [Full Text] [Related]  

  • 23. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
    Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histological structure and prognosis in carcinoma of the bladder].
    Raĭchev R; Sakhatchiev A; Peĭkov Ts; Mushmov M; Krusteva
    Khirurgiia (Sofiia); 1977; 30(2):144-52. PubMed ID: 916566
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of clinical and MR staging of bladder carcinoma.
    McCulloch CJ
    Clin Radiol; 1995 Dec; 50(12):878. PubMed ID: 8536406
    [No Abstract]   [Full Text] [Related]  

  • 26. Bladder cancer: state-of-the-art care.
    Droller MJ
    CA Cancer J Clin; 1998; 48(5):269-84. PubMed ID: 9742894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review on bladder cancer. New rather than old TNM staging system should have been used.
    Millar J
    BMJ; 1999 Mar; 318(7187):875-6. PubMed ID: 10092282
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathological study of growth pattern of bladder cancer from view point of mapping (author's transl)].
    Murase T; Fujita J; Kakizoe T; Matsumoto K; Kishi K
    Nihon Hinyokika Gakkai Zasshi; 1980 Aug; 71(8):829-39. PubMed ID: 7431715
    [No Abstract]   [Full Text] [Related]  

  • 29. Bladder cancer staging.
    MacVicar AD
    BJU Int; 2000 Jul; 86 Suppl 1():111-22. PubMed ID: 10961281
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preoperative balloon occluded arterial infusion chemotherapy for locally invasive bladder cancer--accurate staging for bladder preservation].
    Hayashi N; Arima K; Kawamura J; Tochigi H
    Hinyokika Kiyo; 1999 Feb; 45(2):139-43. PubMed ID: 10212789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?
    Donat SM
    World J Urol; 2006 Nov; 24(5):557-64. PubMed ID: 17009050
    [No Abstract]   [Full Text] [Related]  

  • 32. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Kaynar M; Goktas S
    Urol Oncol; 2015 Nov; 33(11):497. PubMed ID: 26092558
    [No Abstract]   [Full Text] [Related]  

  • 33. The value of intravesical echography combined with double-surface coil magnetic resonance imaging in staging bladder cancer.
    Hendrikx AJ; Barentz JO; vd Stappen WA; Debruyne FM; Ruijs SH
    Br J Urol; 1989 May; 63(5):469-75. PubMed ID: 2659134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.
    Fransen van de Putte EE; Behrendt MA; Pigot GL; van der Kwast TH; van Rhijn BW
    Curr Opin Urol; 2015 Sep; 25(5):427-35. PubMed ID: 26125511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proposed simplified staging system of invasive bladder tumors.
    Herr HW
    Urol Int; 1993; 50(1):17-20. PubMed ID: 8434421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of outcome in bladder cancer.
    Eifler JB; Barocas DA; Resnick MJ
    J Natl Compr Canc Netw; 2014 Nov; 12(11):1549-54. PubMed ID: 25361801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy for bladder cancer: the fight is on.
    Rouprêt M
    World J Urol; 2018 Nov; 36(11):1699-1701. PubMed ID: 30167832
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic factors in Bilharzial-related bladder cancer.
    Susani M; Haitel A; Marberger M
    Hum Pathol; 2004 Sep; 35(9):1167-8; author reply 1168. PubMed ID: 15343522
    [No Abstract]   [Full Text] [Related]  

  • 39. Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: comparison with final pathological stage in invasive bladder carcinoma.
    Yaman O; Baltaci S; Arikan N; Yilmaz E; Gögüs O
    Br J Urol; 1996 Aug; 78(2):197-200. PubMed ID: 8813912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in renal cell and bladder cancer.
    Van Brussel JP; Mickisch GH
    BJU Int; 1999 May; 83(8):902-8; quiz 908-9. PubMed ID: 10368227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.